HeyJaredOladimeji Ewumi
- Indexed articles, last 90 days
- 13
- Latest publication
- Sep 25, 2026
- Outlet visibility, for Endocrinology Advisor
- Top 5M sites
- Earliest in this view
- Jul 15, 2026
Latest articles
Antidiabetic Therapy Lowers Rhinosinusitis-Nasal Polyp Recurrence Risk After Surgery (opens the original)
Read excerpt
Perioperative use of antidiabetic agents is associated with a significantly lower postoperative recurrence rate of chronic rhinosinusitis with nasal polyps (CRSwNP), according to study results published in the American Journal of Rhinology & Allergy. Diabetes mellitus (DM) is increasingly recognized for its capacity to predispose individuals to infectious and inflammatory conditions, including CRSwNP. Several reports indicate that certain antidiabetic agents may exert anti-inflammatory effects;
Cardiovascular Outcomes With Tirzepatide for Obesity and Heart Failure Do Not Differ by Sex (opens the original)
Read excerpt
Among patients receiving tirzepatide for obesity and heart failure with preserved ejection fraction (HFpEF), there were no statistically significant sex-associated differences in major cardiovascular outcomes, according to study findings published in Therapeutic Advances in Cardiovascular Disease. Sex-based disparities are a well-documented feature of HFpEF, yet little real-world evidence currently characterizes how clinical outcomes with tirzepatide compare between men and women among patients
Intensive Glycemic Control Offers Limited Vascular Benefit in Older Adults With T2D (opens the original)
Read excerpt
Intensive glycemic control lowers glycemic levels but does not reduce vascular events and is associated with a higher risk for severe hypoglycemia in adults aged 80 years and older with type 2 diabetes (T2D), according to study results published in Diabetes Research and Clinical Practice. Diabetes prevalence rises with age and exceeds by 20% in individuals aged 65 to 95 years, driven by global population aging, age-related comorbidities, and the ongoing obesity epidemic. Consequently, it remains
Exposure to Antenatal Magnesium Sulphate Beneficial in Extremely Preterm Births (opens the original)
Read excerpt
Administration of antenatal magnesium sulfate (MgSO4) to women at risk for extremely preterm delivery is associated with increased survival without cerebral palsy (CP) or moderate to severe functional impairment by age 2 to 3 years, according to a study published in the American Journal of Obstetrics & Gynecology. CP is the most common childhood physical disability, resulting from nonprogressive brain malformations or injuries. Prevalence rates of cerebral palsy are also considerably higher in l
Semaglutide Exposure in Pregnancy Related to Adverse Outcomes (opens the original)
Read excerpt
Semaglutide exposure before and during pregnancy is associated with a higher risk for adverse outcomes, according to study results published in Obstetrics & Gynecology. The American College of Obstetricians and Gynecologists (ACOG) recommends weight loss before conception for people with obesity. Driven by its substantial weight management and cardiovascular benefits, semaglutide use during the prepregnancy period has increased by 32-fold between 2019 and 2024. Despite guidelines to discontinue
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Endocrinology Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.